Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vinod B. Chavhan"'
Autor:
Prashant N. Chhajed, Preyas J. Vaidya, Neha P. Mandovra, Vinod B. Chavhan, Tejashree T. Lele, Rekha Nair, Jörg D. Leuppi, Avinandan Saha
Publikováno v:
ERJ Open Research, Vol 5, Iss 4 (2019)
This study aimed to examine the use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the rapid diagnosis of mediastinal tuberculous lymphadenitis and drug-resistant mediastinal tuberculous lymphadenitis. A diagnosis
Externí odkaz:
https://doaj.org/article/4344edfbbf5149399424046ba10e16de
Autor:
Avinandan Saha, Preyas J Vaidya, Vinod B Chavhan, Kamlesh V Pandey, Arvind H Kate, Prashant N Chhajed
Publikováno v:
Lung India, Vol 34, Iss 5, Pp 427-429 (2017)
Background: Individualized treatment for multidrug-resistant tuberculosis (MDR TB) is associated with improved outcomes. Therapy needs to be tailored to drug susceptibility testing (DST) results. We present our observations on the inconsistency in DS
Externí odkaz:
https://doaj.org/article/e3149f829ece43198f3fd0c56f7eae00
Autor:
Joerg D. Leuppi, Tejashree T Lele, Prashant N Chhajed, Vinod B Chavhan, Neha P. Mandovra, Anne Leuppi-Taegtmeyer, Preyas J Vaidya
Publikováno v:
Respiration. 99:125-131
Background: Joint pain is frequently observed in patients on antituberculous treatment, and pyrazinamide is known to be associated with joint pain in patients receiving antituberculous treatment. Fluoroquinolone-associated joint pain and tendon injur
Autor:
Joerg D. Leuppi, Vinod B Chavhan, Anne Leuppi-Taegetmeyer, Preyas J Vaidya, Neha Agrawal, Prashant N Chhajed, Ria Shah
Publikováno v:
Idiopathic interstitial pneumonias.
Background: Not all patients with IPF tolerate full dose of PFD (2400mg/day). Aim: To identify factors influencing best tolerated dose of PFD in patients with IPF. Methods: 113 patients (58% males), mean age 65.5years included. PFD was initiated at 6
Autor:
Tejashree T Lele, Preyas J Vaidya, Avinandan Saha, Rekha Nair, Vinod B Chavhan, Neha P. Mandovra, Jörg D. Leuppi, Prashant N Chhajed
Publikováno v:
ERJ Open Research, Vol 5, Iss 4 (2019)
ERJ Open Research
ERJ Open Research
This study aimed to examine the use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the rapid diagnosis of mediastinal tuberculous lymphadenitis and drug-resistant mediastinal tuberculous lymphadenitis. A diagnosis
Autor:
Tejashree T Lele, Rekha Nair, Avinandan Saha, Joerg D. Leuppi, Preyas J Vaidya, Prashant N Chhajed, Vinod B Chavhan, Neha P. Mandovra
Publikováno v:
Interventional pulmonology.
Autor:
Vinod B Chavhan, Prashant N Chhajed, Neha Agrawal, Joerg D. Leuppi, Anne Leuppi-Taegtmeyer, Tejashree T Lele, Preyas J Vaidya
Publikováno v:
Idiopathic interstitial pneumonias.
Background: It was observed that not all patients having idiopathic pulmonary fibrosis (IPF) and were tolerating the full recommended dose of pirfenidone 2400 mg/day. Aims: Examine the best tolerated dose of pirfenidone administered to patients with
Autor:
Vinod B Chavhan, Preyas J Vaidya, Joerg D. Leuppi, Tejashree T Lele, Neha Agrawal, Prashant N Chhajed, Anne B. Taegtmeyer
Publikováno v:
Tuberculosis.
Background: Hyperuricaemia secondary to pyrazinamide (PZA) leading to joint pain is reported. There is paucity of data regarding new onset joint pain in patients receiving anti tuberculous treatment (ATT) in whom PZA is not administered. Fluoroquinol
Autor:
Prashant N Chhajed, Kamlakar Patole, Vinod B Chavhan, Pruthviraj Jaybhaye, Ramakant K Deshpande, Preyas J Vaidya, Kamlesh V Pandey, Arvind H Kate
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 12, Iss 2, Pp 1093-1097 (2016)
Pure endobronchial neoplasms are a rare entity, and they may present with diverse pathological findings. Malignant diseases are more common than benign ones, and they mostly originate from the surface epithelium. Endobronchial tumors usually present
Autor:
Kamlesh V Pandey, Preyas J Vaidya, Avinandan Saha, Prashant N Chhajed, Arvind H Kate, Vinod B Chavhan
Publikováno v:
Lung India : Official Organ of Indian Chest Society
Lung India, Vol 34, Iss 5, Pp 427-429 (2017)
Lung India, Vol 34, Iss 5, Pp 427-429 (2017)
Background: Individualized treatment for multidrug-resistant tuberculosis (MDR TB) is associated with improved outcomes. Therapy needs to be tailored to drug susceptibility testing (DST) results. We present our observations on the inconsistency in DS